IARS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.21099999999641E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.965190E-01
Normal-vs-Stage2
2.39430000004148E-06
Normal-vs-Stage3
8.631800E-01
Normal-vs-Stage4
3.103600E-01
Stage1-vs-Stage2
9.794400E-01
Stage1-vs-Stage3
2.759200E-01
Stage1-vs-Stage4
9.007000E-01
Stage2-vs-Stage3
1.188600E-01
Stage2-vs-Stage4
8.410000E-01
Stage3-vs-Stage4
3.249800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.01829999999714E-05
Normal-vs-AfricanAmerican
1.540370E-02
Normal-vs-Asian
3.150100E-02
Caucasian-vs-AfricanAmerican
1.044790E-01
Caucasian-vs-Asian
3.923400E-01
AfricanAmerican-vs-Asian
4.534800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.73660000000386E-05
Normal-vs-Female
3.00090000004971E-06
Male-vs-Female
5.534600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.602800E-01
Normal-vs-Age(41-60Yrs)
2.36730000002794E-06
Normal-vs-Age(61-80Yrs)
4.35650000000232E-05
Normal-vs-Age(81-100Yrs)
9.698800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.322640E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.258000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.724980E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.506200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.609000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.896800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.918000E-03
Normal-vs-Daily Drinker
7.015500E-02
Normal-vs-Weekly Drinker
4.602200E-02
Normal-vs-Occasional Drinker
3.029900E-04
Normal-vs-Social Drinker
1.712350E-02
Non Drinker-vs-Daily Drinker
5.602200E-01
Non Drinker-vs-Weekly Drinker
6.496600E-01
Non Drinker-vs-Occasional Drinker
2.540800E-01
Non Drinker-vs-Social Drinker
7.197400E-01
Daily Drinker-vs-Weekly Drinker
3.939600E-01
Daily Drinker-vs-Occasional Drinker
1.065970E-01
Daily Drinker-vs-Social Drinker
4.092400E-01
Weekly Drinker-vs-Occasional Drinker
6.614800E-01
Weekly Drinker-vs-Social Drinker
9.109000E-01
Occasional Drinker-vs-Social Drinker
5.119400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.491570E-01
Normal-vs-Grade 2
1.515510E-02
Normal-vs-Grade 3
1.358030E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.616400E-02
Grade 1-vs-Grade 3
9.580600E-03
Grade 1-vs-Grade 4
1.491570E-01
Grade 2-vs-Grade 3
5.128400E-02
Grade 2-vs-Grade 4
1.515510E-02
Grade 3-vs-Grade 4
1.358030E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.087900E-02
Normal-vs-NonDiabetic
2.375400000032E-06
Diabetic-vs-NonDiabetic
1.586420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.061400E-03
Normal-vs-NoPancreatitis
2.0759999999953E-05
Pancreatitis-vs-NoPancreatitis
6.602000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.98242999999154E-05
Normal-vs-N1
2.14039999999471E-05
N0-vs-N1
3.404400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.09890000005764E-07
Normal-vs-TP53-NonMutant
9.045000E-04
TP53-Mutant-vs-TP53-NonMutant
9.295600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
